Pantelis Sarafidis, Roland Schmieder, Michel Burnier, Alexandre Persu, Andrzej Januszewicz, Jean-Michel Halimi, Mustafa Arici, Alberto Ortiz, Christoph Wanner, Giuseppe Mancia, Reinhold Kreutz
In June 2023, the European Society of Hypertension (ESH) presented and published the new 2023 ESH Guidelines for the Management of Arterial Hypertension, a document that was endorsed by the European Renal Association (ERA). Following the evolution of evidence in recent years, several novel recommendations relevant to the management of hypertension in patients with chronic kidney disease (CKD) appeared in these Guidelines. These include recommendations for target office BP < 130/80 mmHg in most and against target office BP < 120/70 mmHg in all patients with CKD; recommendations for use of spironolactone or chlortalidone for patients with resistant hypertension with eGFR higher or lower than 30 ml/min/1...
February 14, 2024: Nephrology, Dialysis, Transplantation